Prior research has revealed that HGSOC cells with CCNE1 amplification display elevated CDK2 expression, and reducing or inhibiting CDK2 could lead to decreased ovarian cancer cell proliferation [52,53]. This evidence concerns the gene CCNE1 and ovarian carcinoma.